1. Home
  2. GTY vs STOK Comparison

GTY vs STOK Comparison

Compare GTY & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Getty Realty Corporation

GTY

Getty Realty Corporation

HOLD

Current Price

$33.91

Market Cap

1.6B

Sector

Finance

ML Signal

HOLD

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

HOLD

Current Price

$33.58

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GTY
STOK
Founded
1955
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
2.0B
IPO Year
1998
2019

Fundamental Metrics

Financial Performance
Metric
GTY
STOK
Price
$33.91
$33.58
Analyst Decision
Buy
Strong Buy
Analyst Count
5
10
Target Price
$32.20
$36.80
AVG Volume (30 Days)
671.7K
667.6K
Earning Date
05-14-2026
04-15-2026
Dividend Yield
5.74%
N/A
EPS Growth
8.00
92.73
EPS
1.35
N/A
Revenue
$221,727,000.00
$184,420,000.00
Revenue This Year
$8.72
N/A
Revenue Next Year
$7.81
$74.28
P/E Ratio
$25.13
N/A
Revenue Growth
9.02
404.50
52 Week Low
$25.39
$5.35
52 Week High
$34.02
$40.22

Technical Indicators

Market Signals
Indicator
GTY
STOK
Relative Strength Index (RSI) 69.12 47.33
Support Level $26.74 $31.60
Resistance Level N/A $35.75
Average True Range (ATR) 0.59 2.37
MACD -0.04 -0.39
Stochastic Oscillator 99.08 23.31

Price Performance

Historical Comparison
GTY
STOK

About GTY Getty Realty Corporation

Getty Realty Corp is the real estate investment trust in the U.S. specializing in the acquisition, financing, and development of convenience, automotive, and other single tenant retail real estate. The company's portfolio includes convenience stores, car washes, automotive service centers (gasoline and repair, oil and maintenance, tire and battery, collision), automotive parts retailers, and certain other freestanding retail properties, including drive-thru quick service restaurants. It generates majority of the revenue in the form of rental income.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: